151 – 200 of 224
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2002
-
Mark
In vitro molecular evolution of antibody genes mimicking receptor revision
(
- Contribution to journal › Article
-
Mark
Antibody evolution beyond nature
(
- Contribution to journal › Letter
-
Mark
Antibody evolution from the centre to the periphery: applied to a human antibody fragment recognising the tumour-associated antigen mucin-1.
(
- Contribution to journal › Article
-
Mark
Chain shuffling to modify properties of recombinant immunoglobulins.
(
- Contribution to journal › Article
-
Mark
Non-germ-line encoded residues are critical for effective antibody recognition of a poorly immunogenic neutralization epitope on glycoprotein B of human cytomegalovirus.
(
- Contribution to journal › Article
-
Mark
Antibody-mediated neutralization of cytomegalovirus: modulation of efficacy induced through the IgG constant region.
(
- Contribution to journal › Article
-
Mark
Functional consequences of insertions and deletions in the complementarity-determining regions of human antibodies
(
- Contribution to journal › Article
-
Mark
Evolving the binding site of aHCMV neutralizing MoAB through fine specificity studies with AD-1 mutants.
2002) Annual Meeting of the Society of Virology, 2002(
- Contribution to conference › Abstract
-
Mark
Expanding antibody sequence space by altering CDR loop lenghts.
2002) Cambridge Healthtech Institute´s Third Annual Recombinant Antibodies conference.(
- Contribution to conference › Abstract
-
Mark
The glycoprotein B specific monoclonal antibody ITC 88 inhibits human cytomegalovirus mediated cell-cell-fusion, not viral attachment.
2002) Annual Meeting of the Society of Virology, 2002(
- Contribution to conference › Abstract
- 2001
-
Mark
A central core structure in an antibody variable domain determines antigen specificity
(
- Contribution to journal › Article
-
Mark
The immune diversity in a test tube - Non-immunised antibody libraries and functional variability in defined protein scaffolds
(
- Contribution to journal › Article
- 2000
-
Mark
Recombining germline-derived CDR sequences for creating diverse single-framework antibody libraries
(
- Contribution to journal › Article
- 1999
-
Mark
Antigenic domain 1 of human cytomegalovirus glycoprotein B induces a multitude of different antibodies which, when combined, results in incomplete virus neutralization
(
- Contribution to journal › Article
-
Mark
Complementarity-determining region (CDR) implantation : A theme of recombination
(
- Contribution to journal › Article
- 1998
-
Mark
Effect of cysteine substitutions on dimerization and interfragment linkage of human cytomegalovirus glycoprotein B (gp UL55)
(
- Contribution to journal › Article
-
Mark
Characterization of bacteriophages by the use of BIAcore(TM) and Origen Analyzer
(
- Contribution to journal › Article
-
Mark
New approach to steroid separation based on a low affinity IgM antibody
(
- Contribution to journal › Article
-
Mark
Three-dimensional structure of a human Fab with high affinity for tetanus toxoid
(
- Contribution to journal › Article
-
Mark
Exploiting sequence space : Shuffling in vivo formed complementarity determining regions into a master framework
(
- Contribution to journal › Article
-
Mark
Insertions and deletions in hypervariable loops of antibody heavy chains contribute to molecular diversity
(
- Contribution to journal › Article
-
Mark
Mouse monoclonal antibodies against outer membrane proteins of a vaccine strain of Neisseria meningitidis B : 4:P1.15
(
- Contribution to journal › Article
- 1997
-
Mark
Altered gene expression associated with apoptosis in a pre-B-leukemic cell line following cross-linking of MHC class I
(
- Contribution to journal › Article
-
Mark
Cytomegalovirus glycoprotein B-specific antibody analysis using electrochemiluminescence detection-based techniques
(
- Contribution to journal › Article
-
Mark
Evaluation of novel control elements by construction of eukaryotic expression vectors
(
- Contribution to journal › Article
- 1996
-
Mark
Light chain shuffling of a high affinity antibody results in a drift in epitope recognition
(
- Contribution to journal › Article
-
Mark
Antibodies specific for the antigenic domain 1 of glycoprotein B (gpUL55) of human cytomegalovirus bind to different substructures
(
- Contribution to journal › Article
-
Mark
Low affinity, antibody binding of an Escherichia coli-derived component
(
- Contribution to journal › Article
-
Mark
Characteristics of human antibody repertoires following active immune responses in vivo
(
- Contribution to journal › Article
-
Mark
Immunoglobulin production induced by CD57+ GC-derived helper T cells in vitro requires addition of exogenous IL-2
(
- Contribution to journal › Article
-
Mark
Selection of binders from phage displayed antibody libraries using the BIAcore(TM) biosensor
(
- Contribution to journal › Article
-
Mark
Light chain shuffling of a cytomegalovirus glycoprotein B-specific antibody results in a modified epitope specificity
(
- Contribution to journal › Article
-
Mark
In vitro immunization of naive human B cells yields high affinity immunuglobulin G antibodies as illustrated by phage display
(
- Contribution to journal › Article
-
Mark
Selection of phage displayed antibodies based on kinetic constants
(
- Contribution to journal › Article
-
Mark
Structural domains involved in human cytomegalovirus glycoprotein B-mediated cell-cell fusion
(
- Contribution to journal › Article
- 1995
-
Mark
Antigen-binding sites dominate the surface properties of IgG antibodies
(
- Contribution to journal › Article
-
Mark
Human antibody reactivity against the lower matrix protein (pp65) produced by cytomegalovirus
(
- Contribution to journal › Article
-
Mark
Generation of diversity in a human anti-viral response
(
- Contribution to journal › Article
-
Mark
A point mutation in a murine immunoglobulin V-region strongly influences the antibody yield in Escherichia coli
(
- Contribution to journal › Article
-
Mark
Molecular characterization of human monoclonal antibodies specific for the human cytomegalovirus : Relationship of variable region sequence to antigen specificity and rheumatoid factor-associated idiotype expression
(
- Contribution to journal › Article
-
Mark
CD4+CD57+ T cells derived from peripheral blood do not support immunoglobulin production by B cells
(
- Contribution to journal › Article
- 1994
-
Mark
Restricted variable region gene usage and possible rheumatoid factor relationship among human monoclonal antibodies specific for the AD-1 epitope on cytomegalovirus glycoprotein B
(
- Contribution to journal › Article
-
Mark
Enhanced ELISA sensitivity using TCA for efficient coating of biologically active lipopolysaccharides or lipid A to the solid phase
(
- Contribution to journal › Article
-
Mark
Site-directed primary in vitro immunization : Production of HIV-1 neutralizing human monoclonal antibodies from lymphocytes obtained from seronegative donors
(
- Contribution to journal › Article
-
Mark
Intra- and extracellular expression of an scFv antibody fragment in E. coli : Effect of bacterial strains and pathway engineering using GroES/L chaperonins
(
- Contribution to journal › Article
-
Mark
Flow cytometric analysis of the stability of antibody production by human × human × mouse heterohybridoma subclones
(
- Contribution to journal › Article
- 1993
-
Mark
Fine specificity and neutralizing activity of human serum antibodies directed to the major antigenic region on gp 116 of human cytomegalovirus
(
- Contribution to journal › Article
-
Mark
Fine specificity of the human immune response to the major neutralization epitopes expressed on cytomegalovirus gp58/116 (gB), as determined with human monoclonal antibodies
(
- Contribution to journal › Article
-
Mark
Effect of cell-derived growth factors and cytokines on the clonal outgrowth of EBV-infected B cells and established lymphoblastoid cell lines
(
- Contribution to journal › Article
-
Mark
Does endogenous glycosylation prevent the use of mouse monoclonal antibodies as cancer therapeutics?
(
- Contribution to journal › Article